Hydroquinone Research Overview
Eukroma Cream 4% is a topical hydroquinone formulation manufactured by Yash Pharma for laboratory research investigating melanin synthesis pathways and depigmentation mechanisms. This dermatological research compound contains 4% hydroquinone as the active ingredient, providing researchers with a standardised preparation for studying tyrosinase enzyme inhibition and melanogenesis modulation in controlled experimental conditions. The cream formulation allows for precise research applications when investigating epidermal melanin distribution and cellular pigmentation responses.
Laboratory Research Applications
Research scientists utilise this hydroquinone preparation to examine melanin biosynthesis inhibition mechanisms and evaluate depigmentation responses in various experimental models. The 4% concentration provides optimal potency for studying tyrosinase enzyme activity suppression and investigating cellular responses to melanin synthesis disruption. Investigators at Stroid UK Shop examine this formulation alongside other dermatological research compounds when studying comparative depigmentation efficacy. Research applications include analysis of melanocyte function modulation, investigation of hyperpigmentation reversal mechanisms, and evaluation of topical delivery system effectiveness. Scientists also study this preparation in conjunction with selective androgen receptor modulators when investigating hormonal influences on pigmentation patterns. Advanced research protocols incorporate this hydroquinone formulation with research peptides to examine synergistic effects on melanin metabolism and cellular pigmentation control mechanisms.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Hydroquinone 4% |
| Manufacturer | Yash Pharma |
| Formulation | Topical cream |
| CAS Number | 123-31-9 |
| Molecular Formula | C₆H₆O₂ |
| Storage Temperature | 15-25°C, dry conditions |
| Research Applications | Melanogenesis studies, depigmentation research |
Research Compliance Statement
This Eukroma Cream 4% hydroquinone preparation is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any form of in-vivo application. Research institutions must ensure appropriate handling protocols and maintain proper laboratory safety standards when conducting studies with this dermatological research compound. All investigators must comply with institutional research guidelines and maintain detailed experimental records when utilising this preparation for melanin synthesis and depigmentation mechanism studies.
